https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/investigation-effectiveness-extended-gene-panel-diagnosis-complex-neurometabolic-phenotypes/
Investigation into the effectiveness of an extended gene panel for the diagnosis of complex neurometabolic phenotypes
14 Dec 2016, 9:45 a.m.

BRC-supported Dr Philippa Mills, Professor Peter Clayton and Professor Paul Gissen have led an investigation into the effectiveness of a gene panel, targeting 614 genes, in establishing a diagnosis for patients presenting with a wide array of neurometabolic phenotypes.
The study looked at the effectiveness of an Inborn Errors of Metabolism gene panel at establishing a diagnosis in patients presenting with a range of neurological features, all of whom had undergone extensive previous investigations but lacked a definitive molecular diagnosis. The panel was shown to be a powerful tool which improved diagnostic ability in the clinical setting.
Despite the large number of genes included, coverage of targeted areas was similar or indeed superior to that for other gene panels. Genetic defects that could, at least partially, explain the observed phenotype could be identified in 53% of patients and when biochemical abnormalities were present this rose to 89%.
The findings suggest that gene panel approaches provide a cost-effective method for testing patients with neurometabolic disorders, enabling a more timely diagnosis, and therefore more prompt treatment inititation.
Currently, patients with suspected neurometabolic disease can undergo extensive and often invasive diagnostic testing. Delays or difficulties establishing a definitive diagnosis are commonly encountered during this process.
Extended gene panels have gained popularity for the diagnosis of genetically heterogeneous conditions providing a rapid method for identifying mutations in genes. This would be of particular benefit for neurometabolic disorders, as early diagnosis is crucial due to early initiation of treatment resulting in more positive outcomes.
The findings of this study have been published in Brain

Patients and public help create multilingual resources for expectant parents
A group of clinicians and researchers at GOSH have developed information about a test offered in pregnancy called prenatal sequencing in the UK’s 12 most common languages.

Cutting-edge genomic technology saves girl from rare brain infection
Great Ormond Street Hospital has launched the UK’s first accredited ‘metagenomics’ testing service, that allows clinicians to identify infections that are otherwise undetectable.

Genomics will revolutionise treatment for childhood rare diseases
A global study has proven the power of a simple genomics blood test to improve treatment and care for childhood epilepsy.

Join us in the countdown to Rare Disease Day 2025
Rare Disease Day takes place annually on the last day of February and is a global opportunity to increase awareness and advocate for those living with rare conditions.